Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 1441 AL 1455

Glia: initiators and progressors of pathology in Parkinson's disease

Halliday GM, Stevens CH.

Mov Disord. 2011 Jan;26(1):6-17. doi: 10.1002/mds.23455.

Excessive daytime sleepiness in patients with Parkinson's disease

Knie B, Mitra MT, Logishetty K, Chaudhuri KR.

CNS Drugs. 2011 Mar;25(3):203-12. doi: 10.2165/11539720-000000000-00000.

Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance

Maccarrone M, Bernardi G, Agrò AF, Centonze D.

Br J Pharmacol. 2011 Aug;163(7):1379-90. doi: 10.1111/j.1476-5381.2011.01277.x.

An accessory bypass tract masked by the presence of atrial fibrillation in a horse

Jesty SA, Kraus MS, Johnson AL, Gelzer AR, Bartol J.

J Vet Cardiol. 2011 Mar;13(1):79-83. doi: 10.1016/j.jvc.2010.10.002. Epub 2011 Feb 15.

Wolff-Parkinson-White syndrome and isoproterenol testing in children: a valid adjunct to predict risk?

Pass RH, Ceresnak SR.

Circ Arrhythm Electrophysiol. 2011 Feb;4(1):8-10. doi: 10.1161/CIRCEP.110.961227.

Efficient and stable transduction of dopaminergic neurons in rat substantia nigra by rAAV 2/1, 2/2, 2/5, 2/6.2, 2/7, 2/8 and 2/9

Van der Perren A, Toelen J, Carlon M, Van den Haute C, Coun F, Heeman B, Reumers V, Vandenberghe LH, Wilson JM, Debyser Z, Baekelandt V.

Gene Ther. 2011 May;18(5):517-27. doi: 10.1038/gt.2010.179. Epub 2011 Feb 17.

TDP-43 in aging and Alzheimer's disease - a review

Wilson AC, Dugger BN, Dickson DW, Wang DS.

Int J Clin Exp Pathol. 2011 Jan 30;4(2):147-55.

Idiopathic Parkinson's disease, osteoporosis, and hip fractures: a case report

Rison RA, Richardson K.

Case Rep Neurol. 2011 Jan 14;3(1):14-7. doi: 10.1159/000323665.

Parkinson's disease and the bones

Gnädinger M, Mellinghoff HU, Kaelin-Lang A.

Swiss Med Wkly. 2011 Feb 16;141:w13154. doi: 10.4414/smw.2011.13154. eCollection 2011.

Blood lactate levels in patients receiving first- or second- generation antipsychotics

Glavina T, Mrass D, Dodig T, Glavina G, Pranić S, Uglešić B.

Croat Med J. 2011 Feb;52(1):41-7. doi: 10.3325/cmj.2011.52.41.

5-HT6 receptor memory and amnesia: behavioral pharmacology--learning and memory processes

Meneses A, Pérez-García G, Ponce-Lopez T, Castillo C.

Int Rev Neurobiol. 2011;96:27-47. doi: 10.1016/B978-0-12-385902-0.00002-4.

Effects of L-DOPA on nigral dopamine neurons and local field potential: comparison with apomorphine and muscimol

Xu D, Karain B, Brantley E, Shi WX.

J Pharmacol Exp Ther. 2011 May;337(2):533-9. doi: 10.1124/jpet.110.177816. Epub 2011 Feb 17.

Olanzapine-induced parkinsonism associated with smoking cessation

Arnoldi J, Repking N.

Am J Health Syst Pharm. 2011 Mar 1;68(5):399-401. doi: 10.2146/ajhp100258.

Engaging neuroscience to advance translational research in brain barrier biology

Neuwelt EA, Bauer B, Fahlke C, Fricker G, Iadecola C, Janigro D, Leybaert L, Molnár Z, O'Donnell ME, Povlishock JT, Saunders NR, Sharp F, Stanimirovic D, Watts RJ, Drewes LR.

Nat Rev Neurosci. 2011 Mar;12(3):169-82. doi: 10.1038/nrn2995.

Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in de novo Parkinson's disease

Oka H, Toyoda C, Yogo M, Mochio S.

J Neural Transm (Vienna). 2011 Sep;118(9):1323-7. doi: 10.1007/s00702-011-0598-5. Epub 2011 Feb 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias